Joel Greenblatt's position in Chemed is currently worth $5.71 Million. That's 0.09% of their equity portfolio (295th largest holding). The first Chemed trade was made in Q1 2011. Since then Joel Greenblatt bought shares 29 more times and sold shares on fifteen occasions. The stake costed the investor $5.5 Million, netting the investor a gain of 3.8% so far.